Safety of Clopidogrel and Aspirin for Stroke Prevention: Implications of the CHARISMA trial

ISSN： 0114-5916

Source： Drug Safety, Vol.31, Iss.6, 2008-01, pp. : 449-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clopidogrel for the secondary prevention of stroke

By Diener Hans-Christoph Ringleb Peter A Savi Pierre

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 755-764

Informa Healthcare

Access to resources Recommend Favorite

Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke

By Greer David M.

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1027-1040

Adis International

Access to resources Recommend Favorite

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness

By Ho Wai Khoon Hankey Graeme J Eikelboom John W

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 493-503

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel beats aspirin for CV event prevention in Germany

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 545, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Aspirin + dipyridamole preferable for stroke prevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite